Gordon Findlay (Novo Nordisk Executive) Wiki, Age
Gordon Findlay Biography – Gordon Findlay Wiki
Gordon Findlay is the global brand director for Novo Nordisk, a pharmaceutical company headquartered in Bagsværd, Denmark. Since 2023, Findlay has been the global brand director for Novo Nordisk, based in Basel, Switzerland. He also handles other marketing duties including new Product Planning, strategic marketing and global marketing.
According to his LinkedIn profile, Findlay previously served as a director for Novartis, an innovative pharmaceutical company based in Basel, Switzerland. He was the director for Global New Product Development from January 2016 to September 2023; director for Global Marketing and Primary Care Franchise from January 2012 to December 2015; and director for Global Strategic Marketing from March 2010 to December 2011.
Findlay also served as a director of marketing at Novartis UK from January 2019 to June 2019. He was also the director of WW Commercial Development at Pfizer from October 2001 to March 2010.
Findlay has a PhD in Biochemistry from the University of Kent. He also holds an MBA from The Open University and a BSc in Biochemistry/ Immunology from the University of Strathclyde.
Gordon Findlay Age
Novo Nordisk executive Gordon Findlay’s age is unknown to the public.
Gordon Findlay Collapse
Novo Nordisk executive Gordon Findlay reportedly collapsed in the Oval Office during an event where President Trump made a statement on lowering the price of weight-loss drugs, including Ozempic.
David Ricks, CEO of Eli Lilly, was giving remarks when he looked to his right and said, “Are you okay? Gordon, are you okay?” Dr. Mehmet Oz jumped in as the drug executive fell to his knees and collapsed. The press were then ushered out and asked to leave. Robert F. Kennedy Jr., the U.S. Health and Human Services Secretary, was also in the room when the incident happened.
About 30 minutes later, when the press conference resumed, Trump gave an update on the executive’s health.
“One of the representatives of the companies, of one of these companies, got a little bit lightheaded,” he told the press. “We saw he went down, and he’s fine. They just sent him out, and he’s got doctors here. But he’s fine.”
The man was identified as Gordon Findlay, the global brand director for Novo Nordisk, though the pharmaceutical company later shared a statement with multiple outlets suggesting that Findlay was not present at the event.
“Please be aware that CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office,” a spokesperson for Novo Nordisk said in a statement.
